TICKERNOMICS Sign up
Last Update: 2024-12-27 15:23:37
AMEDISYS INC ( AMED ) https://www.amedisys.com
85.95USD
Sector:
Healthcare
Industry:
Medical Care Facilities
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-9.56%
AMED
SPY
32.66%
-48.13%
AMED
SPY
108.59%
-48.18%
AMED
SPY
302.52%
AMED
185.83%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
2814.43
2977.30
0.27
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
27.33
1.21
2.34
6.35
0.00
18.09
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
5.16
77.06
7.04
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.0432
6.93
9.01
0.74
Other Earnings and Cash Flow Stats:
AMEDISYS INC ( AMED ) Net Income TTM ($MM) is 102.99
AMEDISYS INC ( AMED ) Operating Income TTM ($MM) is 148.17
AMEDISYS INC ( AMED ) Owners' Earnings Annual ($MM) is 125.65
AMEDISYS INC ( AMED ) Current Price to Owners' Earnings ratio is 24.83
AMEDISYS INC ( AMED ) EBITDA TTM ($MM) is 177.93
AMEDISYS INC ( AMED ) EBITDA Margin is 7.04%
Capital Allocation:
AMEDISYS INC ( AMED ) has paid 0.00 dividends per share and bought back 0.086000000000006 million shares in the past 12 months
AMEDISYS INC ( AMED ) has reduced its debt by 108.045 million USD in the last 12 months
Capital Structure:
AMEDISYS INC ( AMED ) Interest-bearing Debt ($MM) as of last quarter is 408
AMEDISYS INC ( AMED ) Annual Working Capital Investments ($MM) are -72
AMEDISYS INC ( AMED ) Book Value ($MM) as of last quarter is 1200
AMEDISYS INC ( AMED ) Debt/Capital as of last quarter is 35%
Other Balance Sheet Stats:
AMEDISYS INC ( AMED ) has 245 million in cash on hand as of last quarter
AMEDISYS INC ( AMED ) has 486 million of liabilities due within 12 months, and long term debt 381 as of last quarter
AMEDISYS INC ( AMED ) has 32 common shares outstanding as of last quarter
AMEDISYS INC ( AMED ) has 0 million USD of preferred stock value
Academic Scores:
AMEDISYS INC ( AMED ) Altman Z-Score is 3.70 as of last quarter
AMEDISYS INC ( AMED ) Piotroski Score is 9.00 as of last quarter
Corporate Governance:
AMEDISYS INC ( AMED ) largest shareholder is owning shares at 0.00 ($MM) value
Michael Paul North(an insider) Sold 5908 shares of AMEDISYS INC ( AMED ) for the amount of $510628.44 on 2023-03-03
2.32% of AMEDISYS INC ( AMED ) is held by insiders, and 91.32% is held by institutions
AMEDISYS INC ( AMED ) went public on 1994-08-17
Other AMEDISYS INC ( AMED ) financial metrics:
FCF:203.97
Unlevered Free Cash Flow:244.47
EPS:2.07
Operating Margin:5.16
Gross Profit Margin:77.06
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:5.89
Beta:0.74
Buffet's Owners Earnings:125.65
Price to Owner's Earnings:24.83
About AMEDISYS INC ( AMED ) :
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.